Updated:
HilleVax, Inc.
HilleVax, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001888012, and its reported industry is...
Overview
HilleVax, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001888012, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-03-28, it reported net income of USD -147,267,000; total assets of USD 192,690,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- HilleVax, Inc.
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001888012
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2024USD | -$147.3M | $192.7M | $154.5M | -$108.8M | |
| FY2023USD | -$123.6M | $344.4M | $216.7M | -$86.8M | |
| FY2022USD | -$159.8M | $317.2M | $279.4M | -$62.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research HilleVax, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.